Axena Health key facts
as of Oct 2026- Developer of a connected medical device designed to improve outcomes for women with pelvic floor disorders.
- Axena Health is valued at approximately $70.0M as of Oct 2026, set at its early-stage round, Apr 2026; nothing has traded since, per PrivateMarketView’s mark.
- It has raised $45.9M across 2 recorded rounds; the latest was Early Stage VC ($15.0M) in Dec 2025.
- Notable investors include Catalio Capital Management, AXA Investment Managers, AARP, AgeTech Collaborative from AARP, Avestria Ventures — 7 tracked in total.
- Axena Health has filed 2 Form Ds with the SEC since 2023, most recently Apr 2026 ($15.0M sold to 8 investors).
- Status: Privately Held (backing).
Valued at $70.0M at its early-stage round, Apr 2026. Nothing has traded since.
- ·Watch Axena Health: the Monday email on marks, rounds and moves
Axena Health funding rounds
2 roundsAxena Health valuation
Axena Health was valued at $70 million at its early-stage round in Apr 2026. That is the last priced event on record: no secondary trade or institutional fund mark has moved the figure since.
How much has Axena Health raised?
Axena Health has raised $45.9 million across 2 recorded rounds since 2023. The largest was a $26.8 million early-stage round in Jan 2023; the most recent was a $15 million early-stage round in Dec 2025.
Axena Health has filed 2 Form Ds with the SEC since 2023, most recently in Apr 2026 ($15 million sold to 8 investors).
Axena Health investors
7 investors are on record for Axena Health, including Catalio Capital Management, AXA Investment Managers, AARP and AgeTech Collaborative from AARP. The early-stage round in Dec 2025 drew 8 investors.
About Axena Health
Developer of a connected medical device designed to improve outcomes for women with pelvic floor disorders. The company's platform offers a novel, effective, first-line treatment for urinary incontinence (UI) and chronic fecal incontinence (FI), underreported conditions, its patented technology enables non-invasive, drug-free treatment via precise visualization of movement in real-time while monitoring usage and progress, enabling women to strengthen their pelvic floor and decrease the symptoms of stress, mixed and urgency incontinence, including overactive bladder.
- Sector
- Healthcare
- HQ
- Newton, MA, United States
- Founded
- 2023
- Employees
- 47
- Website
- axenahealth.com/
- Ownership
- Privately Held (backing)
Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.